<DOC>
	<DOCNO>NCT01183754</DOCNO>
	<brief_summary>1 . To evaluate role VerifyNow test prognostic marker routine clinical practice use drug-eluting stent . 2 . To determine add-on-effect VerifyNow test beyond conventional risk factor ( clinical , lesion , procedural factor ) . 3 . To compare prognostic utility VerifyNow test several biomarkers .</brief_summary>
	<brief_title>Use Point-of-Care Platelet Function Assay Prediction Atherothrombotic Events</brief_title>
	<detailed_description>Predictive role point-of-care assay ( VerifyNow test ) well evaluate large number patient receive drug-eluting stent routine practice . In addition , additional predictive effect point-of-care assay , compare conventional clinical factor biomarkers , might clinically interesting important .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Consecutive patient establish coronary artery disease receive PCI stent implantation Cardiogenic shock Patients use concomitant medication know affect platelet function aspirin ( i.e . nonsteroidal antiinflammatory agent , dipyramidole , upstream glycoprotein IIb/IIIa inhibitor ) patient know platelet function disorder whole blood platelet count less 150000/Î¼L .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>coronary disease</keyword>
	<keyword>platelet reactivity</keyword>
	<keyword>drug-eluting stent</keyword>
</DOC>